{
    "code": "02019443",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02019443",
    "time": "2016-11-18 19:40:59",
    "許可證字號": "衛署藥輸字第019443號",
    "註銷狀態": "已註銷",
    "註銷日期": "91\/12\/20",
    "註銷理由": "未依本署九十年五月二十三日公告事項一(二)執行",
    "有效日期": "91\/08\/25",
    "發證日期": "81\/08\/25",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201944300",
    "中文品名": "待朗必信靜脈凍晶注射劑５０公絲",
    "英文品名": "DOXORUBICIN MDIJI FOR I.V. INJECTION 50MG",
    "適應症": "急慢性白血球過多症、硬瘤、淋巴瘤、軟纖維性肉廇、交感神經母　　　　　細胞廇、乳癌、肺癌。",
    "劑型": "243凍晶注射劑",
    "包裝": "小瓶",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "DOXORUBICINHCL"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "0302201100  大明產業股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F270011100  DONG-A PHARMACEUTICAL CO., LTD. (ANYANG FACTORY)",
        "製造廠廠址": "410 SUKSU-DONG ANYANG KYUNGGI-DO KOREA252,YONGDU-DONG,DONGDAEMUN-KU,SEOUL,KOREA",
        "製造廠公司地址": "252,YONGDU-DONG,DONGDAEMUN-KU,SEOUL,KOREA",
        "": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1003000610",
            "成分名稱": "DOXORUBICIN HCL",
            "含量描述": "(POTENCY)50",
            "含量": "",
            "單位": "MG"
        }
    ]
}